Pei, Wendi
Fu, Lin
Guo, Wenhuan
Wang, Yibo
Fan, Yong
Yang, Rui
Li, Rong
Qiao, Jie
Yu, Yang http://orcid.org/0000-0002-4310-1966
Funding for this research was provided by:
National Key R&D Program of China (2021YFC2700303)
National Natural Science Foundation of China (82225019, 82192873, 82288102)
Article History
Received: 14 September 2023
Accepted: 14 March 2024
First Online: 3 April 2024
Declarations
:
: For animal experiments, the study entitled “Evaluation of the Efficacy and Safety of Stem Cell Therapy for Ovarian Ageing using Mice” was approved by the Animal Experiment Ethics Committee of Peking University Third Hospital (Date: 15. 02. 2022, No. A2022001) and performed according to the AVMA guidelines. For fat tissue and umbilical cord tissue collection, the study entitled “Study on the Biological Activities of Mesenchymal Stem Cells from Various Sources” was approved by the Research Ethics Committee of the Peking University Third Hospital (Date: 08. 09. 2021, No. M2021325) and was conducted following approved institutional guidelines. Written informed consent was obtained from all donors prior to this study.
: Not applicable.
: The authors declare that they have no competing interests.